Motion Sickness Relief Tablet
Product Images NDC 11673-356

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Motion Sickness Relief (NDC 11673-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

197t- Target- Motion Sickness Relief 8ct (197t Target Motion Sickness Relief 8ct)

This is a detailed text providing information about a motion sickness relief medication in tablet form. The active ingredient is Meclizine HCI 25 mg, which helps prevent and treat nausea, vomiting, or dizziness associated with motion sickness. The medication is to be taken 1 to 2 tablets once daily before activity or as directed by a doctor, with specific warnings for specific health conditions, interactions, and side effects. Inactive ingredients are also listed, and there are guidelines provided for use, warnings, and emergency contact information in case of overdose. For more details or questions, a contact number is mentioned at the end.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.